Exogen Biotechnology is a health startup aimed at developing cutting-edge technologies for organizations and research institutions to monitor DNA damage and to assess DNA repair capacities in a clinical setting. Damage to your DNA can result from normal metabolic processes as well as exposure to exogeneous agents, such as ultraviolet light, ionizing radiation, and some environmental and industrial chemicals. Your ability to repair your DNA upon damage is vital to the integrity of your genome and normal functioning. DNA damage and poor DNA repair has been linked to many diseased states including cancer, neurodegenerative disorders, immunological diseases, and premature aging.
Exogen’s technological platform for assessing DNA damage and repair capacities was developed at the Lawrence Berkeley National Laboratory by a team of scientists and engineers. Exogen was founded in 2012 to translate this new technology to enable rapid processing of tissue specimens and to make testing services affordable and accessible to the public.